Drug intelligence / Profile preview

CHX-Endo

Development stage: Unknown
Lead developer: lege artis Pharma
Modality: Small Molecules
Administration: Topical

Overview

CHX-Endo is a 2% chlorhexidine-based antiseptic solution developed by lege artis Pharma for use as a dental medical device in endodontic treatments. It is specifically designed for the irrigation and disinfection of root canals, targeting persistent pathogens such as *Enterococcus faecalis* and members of the *Enterobacterales* family. The solution aids in the mechanical cleaning of endodontic instruments and significantly reduces bacterial load within the root canal system. It is provided in a specialized 500ml bottle featuring an Easy Syringe Draw (ESD) system to facilitate precise application in clinical settings.

Brand names: CHX-EndoCHX-Endo 2%
Other names: chlorhexidine 2% solution

Targets

LPS (Lipopolysaccharide)

Beyond the preview

Go deeper on CHX-Endo.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CHX-Endo.

Explore the full profile